Research suggests that mutations in ASTE1 are induced by the Epstein–Barr virus in gastric mucosal cells, leading to the autonomous expression of CXCL9 by cancer cells through the NF-κB pathway, increasing IFN-γ in the microenvironment and stimulating immune response. Here, ASTE1 is linked to cancer.